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GABAB receptors are heterodimeric G protein-
coupled receptors composedof R1 andR2 sub-
units thatmediate slow synaptic inhibition in the
brain by activating inwardly rectifying K+ chan-
nels (GIRKs) and inhibiting Ca2+ channels. We
demonstrate here that GABAB receptors are in-
timately associatedwith 50AMP-dependent pro-
tein kinase (AMPK). AMPK acts as a metabolic
sensor that is potently activated by increases
in 50AMP concentration that are caused by en-
hanced metabolic activity, anoxia, or ischemia.
AMPK binds the R1 subunit and directly phos-
phorylates S783 in the R2 subunit to enhance
GABAB receptor activation ofGIRKs.Phosphor-
ylation of S783 is evident in many brain regions,
and is increased dramatically after ischemic in-
jury. Finally,wealso reveal that S783plays acrit-
ical role in enhancing neuronal survival after is-
chemia. Together our results provide evidence
of a neuroprotective mechanism, which, under
conditions ofmetabolic stress or after ischemia,
increases GABAB receptor function to reduce
excitotoxicity and thereby promotes neuronal
survival.
INTRODUCTION
GABAB receptors mediate slow prolonged inhibition in
the brain by activating postsynaptic inwardly rectifying
K+ channels (GIRKs) and inactivating presynapticvoltage-gated Ca2+ channels. GABAB receptors also in-
hibit adenylate cyclase, leading to diminished activity of
PKA signaling pathways (Bowery, 2006). Structurally,
GABAB receptors are members of the class C family of G
protein-coupled receptors (GPCRs) and are encoded in
vertebrates by two genes, GABABR1 and GABABR2, re-
spectively (Bettler et al., 2004; Couve et al., 2004a). In con-
trast to the majority of other GPCRs, heterodimerization
betweenGABABR1 and R2 subunits is required for the for-
mation of functional receptors that reproduce most of the
pharmacological and physiological properties of their na-
tive counterparts (Bettler et al., 2004; Couve et al., 2004a).
Synaptic activity is critically dependent on cellular en-
ergy levels, which are in part determined by the metabolic
sensor 50AMP-dependent protein kinase (AMPK). AMPK
is rapidly activated when cellular levels of ATP fall coinci-
dent with an increase in AMP concentration due to high
metabolic activity or the pathological states of anoxia
and ischemia (Carling, 2005; Kahn et al., 2005). AMPK is
phosphorylated by the upstream kinases LKB1 on threo-
nine 172 (T172) in a process that is stimulated by AMP.
Calmodulin-dependent protein kinase kinase-b (CaMKK)
also phosphorylates T172, and phosphorylation of this
residue by either of these enzymes enhances AMPK cata-
lytic activity (Hawley et al., 2003, 2005; Woods et al.,
2003a; Hurley et al., 2005). AMPK principally mediates
its effect on cellular energy levels by stimulating catabolic
metabolism and simultaneously inhibiting anabolic path-
ways (Kahn et al., 2005). Accordingly, to date the majority
of AMPK substrates identified are either enzymes or tran-
scription factors that control carbohydrate and lipid me-
tabolism (Kahn et al., 2005).
Here we reveal that AMPK binds directly to GABAB
receptors and phosphorylates S783 in the cytoplasmic
tail (C-tail) of the R2 subunit, a process that enhancesNeuron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc. 233
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GABAB Receptor Phosphorylation and IschemiaFigure 1. Association of AMPK with
GABAB Receptors
(A) Interaction of CR1 with AMPK in yeast. A
bait encoding the C-tail of GABABR1 (CR1)
was used to screen a rat brain library, resulting
in the identification of clones encoding AMPK
a1 subunit. The smallest positive which en-
coded amino acids 289–550 of the AMPK a1
subunit was retransformed into yeast with
empty vector (control), CR1, or CR2. Resulting
clones were then tested for b-gal activity;
+++ = +ve,  = ve.
(B) A schematic of the major functional do-
mains within the a1/2 subunits of AMPK. The
catalytic domain (red) with the autophosphory-
lation site T172 and the domains for binding
b and g subunits in addition to GABAB recep-
tors (black) are shown.
(C) In vitro binding of GST-CR1 and AMPK. Fu-
sion proteins were immobilized on GST-aga-
rose and exposed to detergent-solubilized
brain extracts. Bound material was then immu-
noblotted with an antibody for a1/2 subunits of
AMPK. The input lane represents 10% of the
material used in each assay.
(D) Phosphorylation of GST-CR1 by AMPK
from brain lysates. GST-CR1 was exposed to
brain lysates and bound material was exposed
to 32Pg-ATP in the presence and absence of
100 mM 50AMP for 10 min at 37C. Phosphory-
lation was then assessed by SDS-PAGE (upper
panel). The level of 32P incorporation was mea-
sured against controls in the absence of 50AMP
(=100%; n = 3). (*) = significantly different from
control (p < 0.01; Student’s t test).
(E) Immunoprecipitation of AMPK and GABAB
receptors from brain extracts. Crude brain membranes were immunoprecipitated with antibodies that recognize the a1/2 subunits of AMPK. Precip-
itated material was then immunoblotted with antibodies against the GABABR1 and R2 subunits as indicated. Input represents 10% of the material
used for each experiment.
(F) Colocalization of AMPK and GABAB receptors in hippocampal neurons at 12–16 DIV. Neurons were fixed, permeabilized, and stained with anti-
bodies against GABAB receptors and AMPK a1/2 subunits with secondary antibodies conjugated to FITC and rhodamine, respectively. Scale bar,
5 mm.
(G) An enlargement of the boxed area shown in (F).receptor coupling to GIRKs. S783 is basally phosphory-
latedbyAMPKactivity in neurons, andmutation of S783 re-
duces their survival after anoxia. Finally, ischemic injury to
thebrainproduces large increases inS783phosphorylation
within theR2subunit. In cultured neurons this phosphoryla-
tion is important for enhanced neuronal survival after hyp-
oxic insult. Together our results provide evidence of a neu-
roprotectivemechanism inwhichGABAB receptor function
is increased after ischemia to reduce excitotoxicity.
RESULTS
AMPK Binds Directly to GABAB Receptors
To identify signaling molecules that regulate GABAB re-
ceptor functional expression, we searched for cytoplas-
mic binding partners for these proteins. To this end, the
C-tail of the GABABR1 subunit was used as a bait in
a two-hybrid screen of a rat brain cDNA library expressed
in yeast (Couve et al., 2001; Restituito et al., 2005). This234 Neuron 53, 233–247, January 18, 2007 ª2007 Elsevier Incresulted in the identification of residues 289–550 of the
a1 subunit of AMPK as a binding partner for the C-tail of
the GABABR1 subunit, but not for the corresponding do-
main of R2 (Figures 1A and 1B). AMPK holoenzyme is
ubiquitously expressed in all cell types and is composed
of catalytic a1 or a2 subunits together with regulatory
b and g subunits. Residues 289–550 of AMPK a1/2 sub-
units are not required for catalytic activity, but this domain
has been suggested to act as a scaffoldmediating interac-
tion with b and g subunits (Carling, 2005; Kahn et al.,
2005).
To confirm our observations in yeast, we first used
in vitro binding assays. AMPK a1/2 subunits were de-
tected binding to glutathione-S-transferase fusion pro-
teins (GST) encoding the C-tail of the R1 subunit (GST-
CR1) (Couve et al., 2001, 2004b), but not binding to GST
alone, from detergent-solubilized brain extracts (Fig-
ure 1C) as measured by immunoblotting with antibodies
that recognize the a1/2 subunits of AMPK (Fryer et al.,.
Neuron
GABAB Receptor Phosphorylation and IschemiaFigure 2. Identification of AMPK Phos-
phorylation Sites in the Cytoplasmic Tail
of GABAB Receptor Subunits
(A) GABAB receptor C-tails are phosphorylated
by AMPK. GST-CR1 (R1), GST-CR2 (R2), and
GST were phosphorylated in vitro by purified
AMPK for 10 min at 30C. Phosphorylation
was then evaluated by autoradiography (upper
panels) and Coommassie staining (lower
panels).
(B) GST-CR1 and GST-CR2 are phosphory-
lated on serine residues by AMPK. The migra-
tion of phospho-amino acid standards is indi-
cated.
(C) S917 is a major phosphorylation site for
AMPK in GST-CR1. A major peptide that con-
tained a single phospho-serine residue corre-
sponding to S917 in the GABABR1 subunit
was identified using HPLC.
(D) Analysis of GST-CR1 phosphorylation using
site-specific mutagenesis. GST-CR1 (1), GST-
CR1S917A (2), and GST-CR1S917/923A (3) were phosphorylated in vitro using purified AMPK in the presence of 100 mM 50AMP for 10 min at 37C, fol-
lowed by SDS-PAGE and subjection to autoradiography (upper panels) or Coommassie staining (lower panels). The level of phosphorylation for each
mutant was then compared with that seen for GST-CR1, which was given a value of 100%. (*) = significantly different from control (p < 0.01; Student’s
t test; n = 4).
(E) S783 is the major site of phosphorylation for AMPK in GST-CR2. 32P-GST-CR2 was digested with trypsin and the resulting peptides were sepa-
rated byHPLC. The level of 32P in the respective fractionswas then quantified. Themajority of the recovered counts eluted as a single peak, whichwas
subjected to mass spectroscopy (Figure S2). This revealed the presence of a major peptide that contained a single phospho-serine residue corre-
sponding to S783 in GABABR2.
(F) Analysis of GST-CR2 phosphorylation using site-specific mutagenesis. GST-CR2 (1) and GST-CR2S783A (2) were phosphorylated in vitro using
purified AMPK for 10 min at 37C, followed by SDS-PAGE and subjection to autoradiography (upper panels) or Coommassie staining (lower panels).
The level of phosphorylation for the S783Amutant was then comparedwith that seen for GST-CR2, whichwas given a value of 100%. (*) = significantly
different from control (p < 0.01; Student’s t test; n = 5).2002). Using deletion analysis it was evident that residues
910–925 within the coiled-coil domain of the GABABR1
subunit (Bettler et al., 2004; Couve et al., 2004a) are es-
sential in mediating the binding of CR1 to AMPK (data
not shown; Bettler et al., 2004; Couve et al., 2004a). Bound
material was also subjected to in vitro kinase assays.
Phosphorylation of GST-CR1 was evident, which could
be significantly enhanced by 50AMP (Figure 1D). Phos-
phorylation occurred exclusively on serine residues within
a singlemajor phospho-peptide (see Figures S1A and S1B
in the Supplemental Data). No phosphorylation of GST
alone was seen in these assays, a finding consistent
with our previously published studies (Brandon et al.,
1999b). Immunoprecipitation was also used to measure
the association of GABAB receptors with AMPK. Both
R1 and R2 subunits were detected coimmunoprecipitat-
ing with antibodies against the a1/2 subunits of AMPK,
but not with control IgG, from detergent-solubilized brain
extracts (Figure 1E). Finally, we examined the subcellular
distribution of AMPK a1/2 subunits and GABAB receptors
using immunofluorescence in 10–14 DIV cultured hippo-
campal neurons. Significantly, AMPK staining was evident
in neuronal processes and was also found in the nucleus,
consistent with previous studies on the distribution of this
multifunctional signaling molecule (Figure 1F; Carling,
2005; Kahn et al., 2005). GABAB receptor immunoreactiv-
ity was evident in neuronal cell bodies and processes
(Figure 1F) as detailed previously in cultured neuronsN(Couve et al., 2001; Restituito et al., 2005). Strikingly, co-
localization of GABAB receptors with AMPK was evident
for receptor populations close to or on the cell surface
(Figure 1G).
Collectively, our experiments reveal that GABAB recep-
tors can interact directly with AMPK and that these pro-
teins are intimately associated in neurons.
Identification of AMPK-Dependent Phosphorylation
Sites within the GABAB Receptors
We used in vitro phosphorylation to further assess the sig-
nificance of AMPK binding to GABAB receptors. Consis-
tent with our observations from brain extracts (Figure 1D),
purified AMPK phosphorylated GST-CR1 exclusively on
serine residues, while GST alone was not significantly
phosphorylated under the same conditions (Figure 2A).
GST-CR1 was phosphorylated solely on serine residues
(Figure 2B) within a single major tryptic peptide (Figures
S1A and S1B). GST-32P-CR1 phosphorylated to a stoichi-
ometry of 0.3 mol/mol by AMPK and was then subjected
to trypsin digestion, and the resulting peptides were frac-
tionated by HPLC (Figure S2A). This revealed that the ma-
jority of the radiolabel eluted as a single peak, which was
subject to Edman degradation. A singlemajor peptide was
found in these fractions (RHQLQSRQQ) which contained
a single serine residue corresponding to S917 in CR1 (Fig-
ure 2C). To confirm the identity of this site, we compared
the phosphorylation of GST-CR1 and a mutant in whicheuron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc. 235
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Mutation of this residue significantly decreased phosphor-
ylation by AMPK to 70% ± 5.2% of that seen with GST-
CR1 (Figure 2D; p < 0.01). We next compared the patterns
of phosphorylation of GST-32P-CR1 and GST-32P-
CR1S917A by tryptic peptide mapping. For GST-32P-CR1,
phosphorylation occurred within a single major peptide
that was strikingly similar to that seen in the phosphoryla-
tion of GST-CR1 with brain extracts (peptide 1; Figures
S1B and S1C). Mutation of S917 eliminated phospho-
peptide 1; however, a number of new phospho-peptides
became evident, suggesting that mutation of S917 un-
masks other AMPK substrates within CR1 (Figure S1C).
Consistent with this, we found that comutation of S923
with S917 (GST-CR1S917/923A) further reduced AMPK
phosphorylation to 10% ± 5.5% of the level seen with
GST-CR1 (Figure 2D; p < 0.01; n = 4) and eliminated the
majority of the new phospho-peptides seen with
GST-32P-CR1S917A.
We also analyzed whether the C-tail of GABABR2 (GST-
CR2) is a substrate of AMPK. GST-CR2 was phosphory-
lated by AMPK (Figure 2A) and 32P-GST-CR2 migrated
as a doublet, consistent with the instability of this purified
protein as documented previously (Couve et al., 2002).
Phospho-amino acid analysis and peptide mapping re-
vealed that phosphorylation of GST-CR2 occurred exclu-
sively on serine residues within a single major phospho-
peptide (Figure 2B; Figure S1C). 32P-GST-CR2 labeled
to a stoichiometry of 0.15 mol/mol by AMPKwas digested
with trypsin, and the resulting peptides were then sub-
jected to fractionation by HPLC (Figure 2E). The majority
of the counts eluted as a single peak and was further an-
alyzed by HPLC-tandem mass spectroscopy (Figure S2).
Two peptides of 1546.65 Da and 1606.52 Da were
detected. Analysis of collision-induced dissociation (CID)
spectra revealed that these peptides represented the un-
phosphorylated peptide TSTSVTSVNQAS783TSR derived
from the GABABR2 C-tail, and that the same peptide
singly phosphorylated at S783 (Figure S2B). To confirm
the identity of S783 as an AMPK substrate, we prepared
a mutant form of GST-CR2 in which S783 was converted
to an alanine residue (GST-CR2S783A). This mutation
totally abolished AMPK-dependent phosphorylation of
GST-CR2 (Figure 2F).
Thus, our in vitro studies suggest that GABAB receptors
are substrates of AMPK with major phosphorylation sites
at S917 and S783 in the C-tails of the R1 and R2 subunits,
respectively. Interestingly, neither S917 nor S923 conform
to the consensus for phosphorylation by AMPK previously
determined by experiments using synthetic peptides
(Scott et al., 2002). Presumably, the intimate association
of GABAB receptors with AMPK facilitates the phosphory-
lation of nonconsensus sites within these receptors.
Phosphorylation of S783 by AMPK Activity
Decreases GABAB Receptor Rundown
Phosphorylation of the intracellular domains of GPCRs is
critical in regulating their function. Therefore, we mea-236 Neuron 53, 233–247, January 18, 2007 ª2007 Elsevier Incsured whether the activation of AMPK regulates GABAB
receptor effector coupling. To do so we investigated the
activation of K+ channels by recombinant GABAB recep-
tors using HEK-293 cells stably expressing Kir 3.1 and
3.2 channels (GIRK cells) and transiently expressing R1
and R2 GABAB receptor subunits. We conducted time
course studies for membrane currents activated with
a submaximal (10 mM) GABA concentration. Consistent
with previous studies (Couve et al., 2002), internal perfu-
sion with a patch pipette electrolyte containing ATP and
GTP initiated a time-dependent rundown in the GABA-
activated K+ current to 33% ± 3% of control after 22 min
(Figure 3A). Interestingly, inclusion of 1 mM AMP in the
patch pipette solution, in the presence of ATP and GTP,
partially prevented the rundown of the GABA-activated
K+ current to 524% ± 4% after 22 min (Figure 3A) com-
pared with a patch pipette solution containing just ATP
and GTP. The rundown in the GABAB receptor-activated
K+ currents was described by monoexponential decays,
with time constants that appeared independent of the
pipette composition and receptor subunit composition
(Figure S3).
Given that decreasing the ATP:AMP ratio results in the
activation of AMPK (Carling 2005; Kahn et al., 2005), we
tested if the effects of AMP on GABA-activated K+ cur-
rents were dependent upon the AMPK phosphorylation
sites S917 and S783 in the C-tails of the R1 and R2 sub-
units, respectively (Figure 2). GABA concentration re-
sponse curves for R1S917AR2, R1/R2S783A, and wild-type
R1/R2 GABAB receptors (Figure 3B) revealed that the mu-
tations caused only minor rightward lateral shifts. These
shifts were in accord with the 2- to 4- fold reduction in
GABA potency compared with that measured on the
wild-type receptor. The corresponding GABA concentra-
tions at which half of the maximal effect was seen
(EC50s) were: R1/R2, 0.3 ± 0.03 mM; R1
S917AR2, 1.2 ±
0.1 mM; and R1/R2S783A, 0.7 ± 0.1 mM. The stability of
the GABA-activated K+ currents was also assessed for
both of the mutant receptors using a submaximal GABA
concentration (10 mM). Cells expressing R1S917AR2 sub-
units exhibited significant rundown when dialyzed with
ATP and GTP alone (40% ± 2% of control; Figure 3C).
After the addition of 1 mM AMP to the ATP and GTP
pipette solution, GABA responses declined to 57% ± 5%
after 22 min (Figure 3C), which was similar in profile to
the rundown noted for the wild-type receptor (Figure 3A).
In contrast with wild-type or R1S917AR2 GABAB recep-
tors, GABA-activated K+ currents evoked on R1/R2S783A
displayed a different time course profile when the patch
pipette solution was supplemented with 1 mM AMP
(Figure 3D). Initially, using internal solutions containing
ATP and GTP, the current rundowns were quite similar in
profile to those recorded with wild-type receptors (ATP
and GTP alone; 42% ± 6%; Figure 3D). However, the ad-
dition of AMP to the ATP and GTP internal solution had lit-
tle effect on the GABA-activated K+ current rundown
(37% ± 4%; Figure 3D) compared with ATP and GTP
alone. Similar effects of AMPwere seen in cells expressing.
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GABAB Receptor Phosphorylation and IschemiaFigure 3. 50AMP Reduces the Attenuation of GABA-Activated K+ Currents in GIRK Cells via Phosphorylation of S783 in R2
(A) GIRK cells transfected with wild-type GABABR1 and R2 subunits were exposed to 10 mMGABA at the time points indicated, with the internal patch
pipette solutions containing either 2mMATP and 1mMGTP (red circle) or 1mMAMP, 2mMATP, and 1mMGTP (blue triangle) from n = 5–13 cells. All
insets show sample membrane currents (calibration bars 200 pA, 2 s).
(B) Concentration response relationships for R1/R2 (open square), R1S917AR2 (open circle), and R1/R2S783A (black triangle) GABAB receptors
(n = 5–12 cells) with an internal solution containing 14 mM CP, 2 mM ATP, and 1 mM GTP normalized to the maximum GABA peak current
(1 mM) and fitted with the Hill equation (see Experimental Procedures).
(C and D) GIRK cells transfected with R1S917AR2 (C) or R1/R2S783A (D) GABAB subunits were exposed to 10 mMGABA at the time points indicated, with
the internal patch pipette solutions containing either 2mMATP and 1mMGTP (red circle) or 1mMAMP, 2mMATP, and 1mMGTP (blue triangle) from
n = 5–16 cells.
(E–G) Metformin reduces the attenuation of GABA-activated K+ currents of GABAB receptors. GIRK cells transfected with wild-type R1/R2 (E),
R1S917AR2 (F), and R1/R2S783A (G) GABAB subunits were exposed to 10 mMGABA at the time points indicated, with the internal patch pipette solution
containing 2mMATP, 1mMGTP, and 1mMmetformin (black square). Fitted lines taken from (A), (C), and (D) are shown for comparison. Data are from
n = 4–12 cells. All responses have been normalized to the response recorded just after the formation of the whole-cell recordingmode (t = 1). Data are
mean ± SEM. Curves are monoexponential fits to the data points.Neuron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc. 237
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S917A and R2S783A
(data not shown). These data suggest that S783 in the
R2 subunit is responsible for mediating the effects of
AMPK activity on GABAB receptor rundown.
To ensure that AMP was not having an indirect effect on
the GABA-activated K+ current via GABAB receptors, an
AMPK activator, metformin, was used. Metformin acti-
vates the AMPK complex independently of the ATP:AMP
ratio inside the cell (Fryer et al., 2002; Hawley et al.,
2002; Woollhead et al., 2005). Time course profiles for
10 mM GABA-activated K+ currents were constructed for
all three GABAB receptors: R1/R2, R1
S917AR2 and R1/
R2S783A. AMPK was activated by internally perfusing cells
with 1mMmetformin (including ATP and GTP) in the patch
pipette solution. The wild-type receptor and mutants
R1S917AR2 and R1/R2S783A exhibited similar time course
profiles for the GABA-activated K+ currents in the pres-
ence of metformin as they did following the addition of
internal AMP (Figures 3E–3G).
These results suggest that the activation of AMPK, by
either AMP or metformin, and the subsequent phosphory-
lation of S783 on the GABAB R2 subunit, were responsible
for ameliorating the rundown of GABA-activated K+ cur-
rents in GIRK cells.
Production of a Phospho-Specific Antibody against
S783 in GABABR2
Our functional studies have illustrated that AMPKmodula-
tion of recombinant GABAB receptors is critically reliant
upon S783 in the R2 subunit (Figure 3), an in vitro substrate
of this kinase (Figure 2). To further analyze the phosphor-
ylation of this site, an antiserum was raised against a syn-
thetic peptide chemically phosphorylated on the residue
corresponding to S783 (VNQAS-P04TSRL). Affinity puri-
fied anti-pS783 recognized GST-CR2 only when the latter
had been prephosphorylated by AMPK, which was abol-
ished following preadsorption with the phosphorylated
but not dephosphorylated antigen (Figure 4A). We further
analyzed the specificity of pS783 using recombinant ex-
pression GABAB receptors expressed in HEK-293 cells.
For these experiments, transfected HEK-293 cells ex-
pressing GABAB receptors were labeled with NHS-Biotin.
Cell surface receptor populations were purified on immo-
bilized avidin and subjected to immunoblotting. A band of
102 kDa corresponding to the R2 subunit was detected in
cells expressing either R2 or R2S783A subunits using anti-
R2 antibodies (Figure 4B; Couve et al., 2002, 2004b). A
band of identical size, which was specifically blocked by
phosphorylated but not dephosphorylated antigen (Fig-
ure 4B), was evident only in cells expressing R2 subunits.
Using R2 antibodies we compared the cell surface ex-
pression levels of GABAB receptors incorporating wild-
type or R2S783A subunits, and it was evident that mutation
of S783 did not alter cell surface stability of the R2 subunit
(Figure 4D; 105% ± 9.4% of control; n = 4). The effects
of phenformin, a more potent and cell-permeable activa-
tor of AMPK than metformin, on S783 phosphorylation
were assessed (Fryer et al., 2002; Hawley et al., 2002;238 Neuron 53, 233–247, January 18, 2007 ª2007 Elsevier IncWoollhead et al., 2005). This agent produced a large and
highly significant increase in AMPK activity as measured
by enhanced phosphorylation of T172 in AMPK a1/2 sub-
units (Figure 4E; Carling 2005; Kahn et al., 2005). The ef-
fects of phenformin on S783 phosphorylation for cell sur-
face GABAB receptors were assessed by immunoblotting
of biotinylated cell surface fractions. Phenformin treat-
ment produced a large increase in S783 phosphorylation
without modifying R2 cell surface expression levels
(Figure 4E). In these experiments, which used Triton-solu-
ble extracts, R2 often migrated as a doublet when blotted
with anti-p783, which may either reflect degradation upon
sample preparation or a specific phosphorylation-depen-
dent shift in mobility of the R2 subunit.
Together these results reveal that S783 is an AMPK sub-
strate, and that the amelioration of GABAB receptor acti-
vation of GIRKs in HEK-293 cells (Figure 3) was likely to
have been mediated by direct phosphorylation of this
residue.
S783 Is Phosphorylated in the Brain and in Cultured
Neurons
Immunoblotting with anti-pS783 was used to evaluate the
phosphorylation of GABAB receptors in brain extracts.
This antibody recognized a band of 102 kDa identical to
that seen with anti-R2 antibody in membrane fractions
prepared from cerebral cortex, hippocampus, and cere-
bellum, which was abolished by pretreatment with l phos-
phatase (Figure 4F). We further analyzed phosphorylation
of GABABR2 using immunoprecipitation of detergent-sol-
ubilized hippocampal membranes followed by immuno-
blotting. Bands of 102 kDa were seen with both anti-R2
and p783 antibodies immunoprecipitating with R2 anti-
body, but not with control IgG (Figure 4G). The R1 subunit
was also detected coimmunoprecipitating with AMPK an-
tibody, but not with control IgG (Figure 4G).
We next evaluated the phosphorylation of S783 in 10–
14 DIV cultured hippocampal neurons that were treated
with or without 10 mM phenformin. In agreement with
our observations in HEK-293 cells, phenformin produced
a significant increase in AMPK activity asmeasured by im-
munoblotting of p172 (325% ± 45.2% of control; Fig-
ure 4H; p < 0.01, n = 4). To measure the effects on GABAB
receptors, neurons were labeled with NHS-Biotin and cell
surface proteins were isolated on immobilized avidin and
immunoblotted with R2 and pS783 antibodies. This re-
vealed that phenformin significantly enhanced surface re-
ceptor S783 phosphorylation to 185% ± 20.2% of control
(Figure 4H; p < 0.01) without significantly altering total R2
expression levels (Figure 4H; 110% ± 11%).
Immunofluorescence was used to further analyze the
distribution of phosphorylated GABAB receptors in cul-
tured hippocampal neurons. At 12–14 DIV neurons were
fixed, permeabilized, and stained with anti-pS783. This
antibody labeled neurons by the soma and neuronal pro-
cesses and was blocked by the phosphorylated peptide
antigen, but not by its nonphosphorylated equivalent
(Figure S4). We also compared the distribution of pS783.
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GABAB Receptor Phosphorylation and IschemiaFigure 4. Analyzing S783 Phosphorylation in Expression Sys-
tems, Cultured Neurons, and the Brain
(A) Specificity of pS783 antibody. GST-CR2 was transferred to a mem-
brane with (+), or without () in vitro phosphorylation by AMPK and
probed with affinity purified pS783 antibody alone or with antibody
that had been preabsorbed with a 500-fold molar excess of phospho-
(P-pep) or dephospho-antigens (Pep).
(B) Cell surface GABAB receptors are phosphorylated on S783. Mock
transfected HEK-293 cells (lane 1) and those expressing GABAB re-
ceptors composed of R1R2 (2) or R1R2S783A (3) subunits were labeled
with NHS-Biotin and cell surface proteins and were immunoblotted
with antibodies against R2 subunits or pS783. Blots with pS783 were
also performed with antibody that had been preabsorbed with a 500-
fold molar excess of phospho (P-pep) and dephospho-antigens (Pep).
(C) Cell surface expression levels of GABABR2 (open bar, set to 100%)
and R2S783A (filled bar) subunits when coexpressed with R1 subunits,
measured by immunoblotting with antibodies against the R2 subunit
(n = 4).
(D) Phenformin activates AMPK activity in HEK-293 cells. Cells ex-
pressing R1R2 GABAB receptors were treated with 10 mM phenformin
for 1 hr, then immunoblotted with antibodies against the AMPK a1/2
subunits and p172. The ratio of a1/2/p172 signals was then calculated
from control cells (open bar) and from those treated with phenformin
(filled bar) (n = 4).
(E) Phenformin treatment enhances S783 phosphorylation. HEK-293
cells were treated with (+) or without () 10 mM phenformin andNstaining with that for total R2 subunits using double immu-
nofluorescence. Immunoreactivity for pS783 and R2 was
evident in the cell bodies and neuronal processes of cul-
tured hippocampal neurons (Figure 4I). We compared
the colocalization of cR2 and p783 immunofluorescent
puncta for pS783 and R2 on neuronal processes.
84.74% ± 10.2% (n = 4) of pS783 puncta also contained
immunoreactivity for R2. In contrast, only 25% ± 4.5%
(n = 5) of R2 puncta contained immunoreactivity for
pS783. This discrepancy most likely reflects the fact that
not all GABAB receptors containing R2 subunits are phos-
phorylated on S783; consistent with this, treatment of cul-
tured neurons with the AMPK activator metformin robustly
increased phosphorylation of this residue (Figure 4H).
Together these biochemical studies demonstrate that
GABAB receptors in both the brain and cultured neurons
are phosphorylated on S783 in the R2 subunit, and
strongly suggest a role for AMPK activity in regulating
the phosphorylation of this residue.
Phosphorylation of S783 in Hippocampal Neurons
Is Dependent upon AMPK Activity
Given the paucity of specific AMPK inhibitors, we used
a genetic approach to further elucidate the role of this ki-
nase in regulating GABAB receptor phosphorylation. To
do so we utilized a dominant-negative a1 subunit expres-
sion construct in which aspartate 157 had been mutated
to an alanine residue and modified with a myc epitope
(DNa1; Woods et al., 2000). This construct is catalytically
inactive but can still assemblewith kinase b and g subunits
labeled with NHS-Biotin. Cell surface proteins were then denatured
and subjected to immunoprecipitation with R2 antibodies or control
IgG. Precipitated material was immunoblotted with R2 or pS783 anti-
bodies. In the experiment shown, phenformin produced a 2.5-fold in-
crease in R2S783 phosphorylation without altering cell surface expres-
sion levels of this receptor subunit. Similar results were seen in three
other independent experiments.
(F) S783 is basally phosphorylated in the brain. Membrane protein pre-
pared from rat cortex (1), hippocampus (2), and cerebellum (3) were
immunoblotted with p783 and R2 antibodies as indicated with (+) or
without () prior treatment of the membrane with l phosphatase.
(G) Analysis of S783 phosphorylation via immunoprecipitation. Hippo-
campal extracts were immunoprecipitated with anti-R2 antibody or
control IgG. Precipitated material was then immunoblotted with anti-
bodies for p783, R2, and R1 as indicated.
(H) Phenformin activates AMPK and enhances S783 phosphorylation
in neurons. Twelve- to fourteen-day-in-vitro hippocampal neurons
were treated with 10 mM phenformin for 1 hr and treated with NHS-
Biotin. Cell surface fractions were then immunoblotted with AMPK
a1/2, p172, anti-R2, and anti-p783 antibodies as indicated. The ratios
of a1/2/p172 and R2/p783 were then calculated from control cells
(open bars) and those treated with phenformin (filled bars). (*) = signif-
icantly different from control (p < 0.01; Student’s t test; n = 5). The
levels of cell surface GABABR2 subunits were unaltered by phenformin
(110% ± 11.2%; n = 3; data not shown).
(I) Confocal analysis of p783 phosphorylation. Twelve- to fourteen-
day-in-vitro hippocampal neurons were stained with R2 and pS783
antibodies coupled to rhodamine and FITC-conjugated secondaries,
respectively (left-hand panel, scale bar = 10 mm). The right panels
represent enlargements of the boxed area in the left-hand panel.euron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc. 239
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imental systems (Carling, 2005; Kahn et al., 2005). Twelve-
to twelve-day-in-vitro hippocampal neurons were trans-
fected with a plasmid encoding DNa1, and effects on
GABAB receptor phosphorylation were then evaluated
24–48 hr later using triple immunofluorescence and
high-resolution confocal microscopy. In neurons express-
ing DNa1, as revealed by high levels of myc staining, there
appeared to be a reduction in S783 fluorescence com-
pared with that of nontransfected neurons, while the levels
of R2 staining appeared similar (Figure 5A and 5B). To
Figure 5. Analyzing the Effects of Modulating AMPK Activity
on GABAB Receptor Phosphorylation in Hippocampal
Neurons
Twelve- to fourteen-day-in-vitro cultured hippocampal neurons were
transfected with a plasmid encoding myc-tagged DNa1. Twenty-four
to forty-eight hours after transfection, neurons were fixed, permeabi-
lized, and stained with antibodies specific for GABABR2 subunits
(secondary antibody conjugated to rhodamine) and specific for myc
(secondary antibody conjugated to FITC). Neurons were also stained
with anti-pS783 antibodies (A–B) or pS892 (C–D) conjugated to Alexa
405. Images were recorded from both untransfected neurons (A and C)
and those expressing DNa1 (B and D) using the same microscope
settings. Scale bars, 5 mm.quantify these results we compared the number of R2
240 Neuron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc.puncta containing pS783 immunoreactivity (R2/p783
colocalization) with data being normalized to values seen
in control neurons (=100%). The number of R2 puncta
containing p783 immunoreactivity in DNa1-expressing
neurons identified via their myc fluorescence decreased
significantly to 21% ± 4.5% of the level seen in control
nonexpressing neurons (Figure 6A). To control for possible
nonspecific effects of DNa1 expression, we analyzed the
level of phosphorylation of S892, a substrate of PKA, using
another phospho-specific antibody against this site (anti-
pS892; Couve et al., 2002). In both control neurons and
those expressing DNa1, very similar levels of colocaliza-
tion between pS892 and R2 staining were evident (Figures
5C and 5D and Figure 6A). As a final control we assessed
the effects of expressing GFP on the phosphorylation of
both S783 and S892, which revealed that expression of
this protein did not alter the levels of either S783 or S892
phosphorylation (Figure 6A).
Together these results in hippocampal neurons demon-
strate that overexpression of a dominant-negative AMPK
catalytic subunit can specifically decrease S783 phos-
phorylation, strongly suggesting that basal phosphoryla-
tion of this site is dependent upon AMPK activity.
AMPK Modulates GABAB Receptor Function
in Hippocampal Neurons
As neuronal AMPK was capable of phosphorylating
GABAB receptors, we next determined whether such
phosphorylation could affect native GABAB receptor func-
tion. We utilized different patch pipette solutions while
making whole-cell recordings from cultured hippocampal
neurons at 7–14 DIV and employed baclofen as the
GABAB agonist to avoid the activation of native GABAA re-
ceptors. As noted previously in HEK-293 cells expressing
recombinant GABAB receptors, the activation of K
+ cur-
rent by 10 mM baclofen exhibited significant rundown to
50% ± 5% of the level observed at zero time when
dialyzed with electrolyte containing ATP and GTP (Fig-
ure 7B). To assess the role of AMPK in modulation of
GABAB receptor function, metformin (10 mM) was added
to the patch pipette solution (with ATP andGTP) to directly
activate AMPK without altering the intracellular ATP:AMP
ratio. Metformin significantly reduced rundown to 68% ±
11% of the level seen at zero time (Figure 7B; p < 0.01,
n = 4–12 cells). Overall, these data suggest that the activa-
tion of AMPK, and hence phosphorylation of S783 in
neurons, can maintain the stability of baclofen-activated
K+ currents.
S783 Phosphorylation in the Hippocampus
Is Enhanced by Ischemic Brain Injury
Anoxia and ischemia lead to rapid activation of AMPK
(Carling, 2004; Kahn et al., 2005; Gadalla et al., 2004;
McCullough et al., 2005; Ramamurthy and Ronnett,
2006). We therefore sought to test whether ischemic brain
injury after transient occlusion of the middle cerebral ar-
tery occlusion (MCAO) modifies GABAB phosphorylation
in rats (Belayev et al., 1996; Longa et al., 1989). After injury
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GABAB Receptor Phosphorylation and IschemiaFigure 6. AMPK Modulates GABAB Receptor Phosphoryla-
tion and Function in Hippocampal Neurons
(A) AMPK activity mediates basal phosphorylation of S783. Data for
pS783, pS892, and R2 fluorescence levels were calculated from con-
trol nontransfected neurons and those expressing DNa1 (see Figure 5).
This data was then used to determine the colocalization of pS783/R2
and pS892/R2 signals in both nontransfected neurons (open bars)
and those expressing either DNa1 or GFP (filled bars) as indicated
(controls = 100%). (*) = significantly different from control (p < 0.01;
Student’s t test, n = 20–35 neurons in three separate transfections).
(B) AMPK activity modulates GABAB receptor activity in hippocampal
neurons. Hippocampal neurons (7–14 DIV) were exposed to 10 mM
baclofen at the time points indicated, with the internal patch pipette
solution containing either 2 mM ATP and 1 mM GTP (red circle) or
2 mM ATP, 1 mM GTP, and 1 mM metformin (black square) from
n = 5–12 cells. Response amplitudes have been normalized to the
response recorded just after the formation of the whole-cell recording
mode (t = 1). Data are mean ± SEM. Curve fits are monoexponential
decays. All recordings were carried out in the presence of high K+Nrats were allowed to recover for 80 min before perfusion
with 4% paraformaldehyde. It is well established MCAO
produces a specific hemispheric injury (Belayev et al.,
1996; Longa et al., 1989). To detect the location of the in-
farct in our experiments, coronal brain sections from
treated and untreated animals were first stained with
anti-pS783 and then with secondary antibodies conju-
gated to HRP before visualization with DAB followed by
microscopy. In the animal shown in Figure 7A, the area
of ischemic damage (+) was localized to the left-hand
side of the brain, as measured by the drastic loss of
pS783 staining in a large infarct that centered on the cau-
date/putamen. In contrast the right side of the brain
[Figure 7A ()] remained undamaged and was similar to
the same brain regions from control animals (Figure 7B).
After identifying the area of brain injury, we proceeded to
examine S783 phosphorylation in the hippocampus for
comparison with our studies in cultured neurons. Strik-
ingly, enhanced immunoreactivity in the CA3 and dentate
gyrus (DG) was seen for the pS783 antibody only in the in-
jured side of the brain (Figures 7C, 7E, and 7G, black box),
while the uninjured side of the brain (Figures 7C, 7F, and
7H, red box) exhibited levels of staining similar to those
of control animals (Figure 7D). However, the levels of
pS892 and R2 staining appeared unaltered in both the is-
chemic and uninjured sides of the brain (Figure 7I and 7J).
To further analyze the level of GABAB receptor phosphor-
ylation in these experiments, we directly compared optical
density measurements of immunoreactivity between the
varying regions of injured and control hippocampi and
the corresponding areas of untreated animals usingMeta-
Morph analysis. This revealed that ischemic injury pro-
duced large and highly significant increases in S783
phosphorylation within the CA3 and DG areas while the
levels of R2 subunit immunoreactivity remained unaltered
(Figure S4).
To examine the subcellular sites of S783 phosphoryla-
tion, we stained hippocampal sections from ischemic
brain with antibodies against p783 and parvalbumin,
a marker for some interneurons (Celio, 1990). Immunoflu-
orescent images were then collected by confocal micros-
copy, revealing that p783 staining was found in parvalbu-
min-positive interneurons (Figure 8A). Strong p783
immunoreactivity was also evident in distinct puncta
within the pyramidal layer of CA3 (Figure 8A). These results
demonstrate that S783 is phosphorylated in GABAergic
interneurons and strongly suggest that this site is also
phosphorylated in glutamatergic pyramidal neurons.
S783 Promotes Neuronal Survival after Chemical
Anoxia
To further analyze the role of S783 in ischemia, we used
cultured hippocampal neurons (10–14 DIV) and evaluated
Krebs solution containing 20 mM AP-5, 10 mM CNQX, 500 nM TTX,
and 25 mM bicuculline.
(C) Typical GABA-activated K+ currents recorded from hippocampal
neuronsusing internal solutions as indicated (calibrationbar, 40pA, 1s).euron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc. 241
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and 10 mM azide; Imura et al., 1999; Kume et al., 2002)
would activate AMPK and enhance GABAB receptor
phosphorylation. In agreement with our studies in whole
animals, anoxic insult significantly increased the phos-
phorylation of S783 in GABAB receptors and T172 in
AMPK. 180 min after anoxia, their phosphorylation in-
Figure 7. S783 Phosphorylation Is Enhanced in the Hippo-
campus after Ischemic Brain Injury
Rats subjected to ischemic injury and aged-matched controls were
cardiac perfused and 40 mm brain sections were prepared. These
sections were then subjected to immunohistochemistry using perox-
idase/DAB staining for anti-pS783 (A–H), anti-pS892 (I), and anti-R2
(J). (A) Coronal sections at the caudate putamen level showing ische-
mic tissue on the left hemisphere. (B) Section through the caudate
putamen in animals with no ischemic injury. (C) Hippocampal level
of ischemic brain showing the ischemic hemisphere on the left. (D)
Hippocampal level of control animal. (E) Expansion of the black box
in (C) showing the pyramidal cell layer of CA3 (arrows) and the gran-
ular layer of the DG from ischemic brain. (F) Expansion of the red box
in (C) from uninjured tissue. (G) Magnification of the CA3 region show-
ing intense staining in the pyramidal cell layer of the ischemic hemi-
sphere. (H) Magnification of CA3 of the nonischemic hemisphere.
(I and J) Coronal hippocampal sections of ischemic (+) and uninjured
() rat brain.242 Neuron 53, 233–247, January 18, 2007 ª2007 Elsevier Increased by 330.20%± 32%and 350.40%± 45%, respec-
tively (p < 0.01), without significantly altering the total
cellular levels of these proteins (Figure 8B).
We next evaluated the effects overexpressing FLAG-
tagged GABABR2
F or R2FS783A subunits (Couve et al.,
2002) on the survival of cultured neurons after anoxia.
For these experiments we utilized nucleofection to ex-
press these differing transgenes in cultured neurons,
a technique previously established to produce transfec-
tion efficiencies of approximately 35% (Kittler et al.,
2004; Couve et al., 2004b). To assess transgene expres-
sion, 10–14 DIV nucleofected neurons were immunoblot-
ted with FLAG antibodies. This revealed the expression
of bands of 102 kDa in neurons nucelofected with
GABABR2
F or R2FS783A subunits, but not in control cul-
tures (Figure 8C). Significantly, expression of recombinant
R2 subunits did not alter the overall expression levels of
these proteins in nucleofected neurons or the levels of
AMPK a1/2 subunits (Figure 8C). To measure the effect
of S783 on survival, expressing neurons were exposed
to a 15 min anoxic insult, cultured for a further 15 hr, and
stained with trypan blue to assess viability (Figure 8D).
This analysis revealed that survival for neurons expressing
wild-type GABABR2
F was 60.20% ± 2.3%, while survival
for neurons expressing R2FS783A subunits was signifi-
cantly reduced by 11.08% to 49.12% ± 2.2% (p < 0.01).
After controlling for the efficiency of nucleofection, muta-
tion of S783 decreases neuronal survival by approximately
31% after ischemia.
Together these in vitro observations provide the first di-
rect evidence that we know of that S783 can modulate
neuronal survival after anoxic injury.
DISCUSSION
GABAB receptors are critical heterodimeric GPCRs which
are important for the induction of slow and prolonged syn-
aptic inhibition in the brain (Bowery, 2006). However, what
has remained largely enigmatic is whether other signal
transduction pathways are capable of exerting long-term
regulation over GABAB receptor function. Here we reveal
that functional heteromeric GABAB receptors composed
of R1/R2 subunits directly bind to, and are phosphorylated
by, AMPK, which then influences their function. The iden-
tification of S783 on the R2 subunit as an AMPK substrate
has subsequently allowed us to reveal a link between the
induction of ischemia and increased phosphorylation of
GABAB receptors in the hippocampus. During ischemia
intracellular ATP levels decrease and Ca2+ levels increase
(Choi, 1998), which leads to the activation of kinases up-
stream of AMPK, including LKB1 and CaMKK (Hawley
et al., 2005; Hurley et al., 2005; Woods et al., 2003a;
2003b). This increase in GABAB receptor phosphorylation,
evident during ischemia, is predicted to enhance receptor
effector coupling and provides a new and potentially neu-
roprotective mechanism that may limit neuronal exposure
to excitotoxicity.c.
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(A) Analysis of the subcellular sites of S783 phosphorylation in the hippocampus using confocal microscopy. Hippocampal sections from MCAO an-
imals were stained with antibodies against S783 and parvalbumin, a marker for subsets of interneurons, with secondary antibodies FITC and rhoda-
mine, respectively. Arrows indicate parvalbumin-positive interneurons, and white arrowheads represent parvalbumin-negative interneurons. PL,
pyramidal cell layer; RL, stratum radiatum. Scale bar, 10 mm.
(B) Anoxia increases AMPK activity and S783 phosphorylation. Twelve- to fourteen-day-in-vitro hippocampal neurons were given a 5 min anoxic in-
sult, re-fed, and incubated at 37C for either 15 or 180 min as indicated. Neurons were then lysed and immunoblotted with antibodies against p783,
GABABR2 (R2), p173, and AMPK a1/2 subunits (n = 4–5).
(C) Expression of recombinant GABAB receptors in hippocampal neurons. Ten- to fourteen-day-in-vitro hippocampal neurons expressing either
GABABR2
F or GABABR2
FS783A subunits were lysed and immunoblotted with FLAG antibodies.
(D) Mutation of S783 in GABABR2 decreases neuronal survival 24 hr after anoxia. Neurons were stained with trypan blue and viability was calculated
as a percentage of unstained cells (viable cells) related to the total number of cells counted (viable cells plus nonviable cells). At least 300 cells were
counted on each coverslip. (*) = significantly different from control (p < 0.01; Student’s t test, n = 3).GABAB Receptors as Substrates for AMPK
By using yeast two-hybrid screens, in vitro binding/kinase
assays, immunoprecipitation, and immunofluorescence
assays, it is clear that the interaction of GABAB receptors
and AMPK is mediated initially by the direct binding of the
kinase a1/2 subunits to the C-tail of the GABABR1 subunit.
Interestingly, AMPKphosphorylated theC-tails of both the
GABABR1 and R2 subunits in vitro, and this phosphoryla-
tion occurred exclusively on serine residues. We subse-
quently identified two major sites of AMPK phosphoryla-
tion: S917 and S783 in the C-tails of GABABR1 and R2
subunits, respectively.
Functional Modulation of GABAB Receptors
by AMPK
A number of binding partners for GABAB receptors have
been identified to date, including 14-3-3 isoforms, ATF4/
CREB2, and Marlin-1, but the precise role that these bind-
ing partners play in regulating GABAB receptor functional
expression remains to be determined (Couve et al.,
2004a).While AMPK has been established as an important
regulator of the cellular levels of ATP via inhibition of ana-
bolic metabolism and activation catabolic pathways (Carl-
ing, 2004; Kahn et al., 2005), our results now suggest a role
for this kinase in modulating inhibitory neurotransmitter
receptors. Using patch-clamp recording, the coupling of
GABAB receptors to GIRKs in HEK-293 cells typically
exhibited significant levels of rundown when activated by
GABA, despite the internal solution containing ATP and
GTP. When this was supplemented by AMP or metformin,
rundown was substantially ameliorated, suggesting thatNthe activation of AMPK was instrumental in this modula-
tion. By using mutagenesis we were able to determine
whether both GABAB receptor subunits needed to be
phosphorylated for AMPK to regulate receptor function.
From this approach it was evident that the functional ef-
fects of AMPK were mediated via S783 on R2, rather
than S917 on R1. We therefore proposed that the C-tail
of the R1 subunit was more likely to mediate the binding
of AMPK to GABAB receptors rather than transduce any
functional effect. Consistent with this role for R2, we
have demonstrated that phosphorylation of this subunit
by PKA on S892 also alleviates GABAB receptor rundown
by enhancing its activation of GIRK channels (Fairfax et al.,
2004; Couve et al., 2002).
Direct Phosphorylation of Neuronal GABAB
Receptors
To directly measure the phosphorylation of S783, we
raised a phospho-specific antibody against this residue.
Using pS783 we were able to confirm that this residue
was basally phosphorylated in HEK-293 cells, rat brain
membranes, and cultured hippocampal neurons. The level
of phosphorylation of S783 was significantly enhanced af-
ter AMPK activation with phenformin. Phosphorylation of
S783 did not modify the cell surface expression levels of
GABAB receptors in these various cell systems. This sup-
ports a number of studies showing that neuronal GABAB
receptors do not undergo agonist- or PKA-induced inter-
nalization (Couve et al., 2004a).
To directly evaluate S783 phosphorylation in neurons,
we employed a dominant-negative a1 AMPK subuniteuron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc. 243
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exist. In neurons expressing DNa1, a large decrease in the
phosphorylation of S783 was evident. However, phos-
phorylation of S892, a residue predicted to be adjacent
to S783 in GABABR2 and previously identified as a PKA
substrate, remained unaltered. These results demonstrate
that neuronal GABAB receptors are indeed phosphory-
lated on S783 and that AMPK activity plays a critical role
in regulating the phosphorylation of this residue. To exam-
ine the functional consequences of AMPK phosphoryla-
tion on the activity of neuronal GABAB receptors, electro-
physiological analyses were utilized. In agreement with
our recombinant data, the activation of GIRK channels
by GABAB receptors again exhibited rundown under con-
trol conditions. This rundown was largely abrogated using
a patch pipette solution supplemented with metformin.
These results provide strong evidence of a role for
AMPK activity in regulating GABAB receptor effector cou-
pling in neurons.
Modulation of AMPK after Ischemic Insult
Given the critical role AMPK activity plays in conserving
cellular levels of ATP, we considered that its ability to en-
hance GABAB receptor functional coupling may be signif-
icant under conditions of metabolic stress. This type of
stress could be imposed on a cell by persistent neuronal
depolarization, or alternatively, it can manifest during an-
oxic or ischemic injury; all of which are conditions known
to decrease cellular levels of ATP or increase Ca2+ levels
and lead to the robust activation of AMPK (Carling,
2004; Kahn et al., 2005; Gadalla et al., 2004; McCullough
et al., 2005; Ramamurthy and Ronnett, 2006). To test our
hypothesis we analyzed the phosphorylation of GABAB
receptors after ischemic injury to the brain induced by
MCAO. This insult revealed a large increase in the phos-
phorylation of S783 in CA3 and DG, but not in the CA2 re-
gions of the hippocampus. In contrast, the phosphoryla-
tion of S892 in GABABR2 remained unaltered, as did the
overall expression levels of R2.
To provide further insight into the possible role of S783
phosphorylation in ischemia, we examined the effects of
anoxia on cultured hippocampal neurons. Anoxia signifi-
cantly increased AMPK activity and enhanced phosphor-
ylation of S783, consistent with our studies in whole
animals. Moreover, using overexpression of R2, we estab-
lished that mutating S783 significantly decreased neuro-
nal survival compared with neurons expressing wild-type
GABABR2 subunits. Thus, our in vivo and in vitro results
suggest that ischemic/anoxic injury leads to an increased
phosphorylation of S783, which increases GABAB recep-
tor activation of postsynaptic GIRK channels, leading to
increased membrane conductance and thereby limiting
neuronal activity. If such an effect was also manifested
presynaptically, then we would predict that AMPK should
also increase the inactivation of Ca2+ channels via GABAB
receptor activation, leading to decreased release of gluta-
mate, GABA, and a range of other neurotransmitters,
which may have varying effects on neuronal survival.244 Neuron 53, 233–247, January 18, 2007 ª2007 Elsevier IncHowever, it is interesting to note that GABAB receptor ag-
onists are neuroprotective in animal models of ischemia,
further highlighting a predominant role for these receptors
in limiting neuronal activity after ischemic/anoxic injury
(Kulinskii and Mikhel’son, 2000; Dave et al., 2005; Jack-
son-Friedman et al., 1997). Finally, and in agreement
with these whole animal studies, we were able to establish
that phosphorylation of S783 appears to play a neuropro-
tective role in cultured neurons after anoxia.
In conclusion, we have uncovered a role for AMPK in
binding to and phosphorylating GABAB receptors, a pro-
cess which enhances their functional coupling to K+ chan-
nels. Given that AMPK has a unique ability to respond to
decreased cellular levels of ATP, this mechanism, which
relies on a single phosphorylatable serine residue in the
R2 subunit, may act to decrease synaptic activity under
conditions of intense metabolic stress or ischemic injury
to conserve cellular energy levels in addition to limiting
neuronal injury via excitotoxicity.
EXPERIMENTAL PROCEDURES
Antibodies
Rabbit antibodies against p172 in AMPK were purchased from Cell
Signaling Systems. Rabbit polyclonal antibodies against the a1/2 sub-
units have been detailed previously (Fryer et al., 2002). Anti-pS783 was
raised in rabbits against the synthetic peptide VNQApSTSRL, and the
resulting antisera was sequentially purified on dephospho- and
phospho-antigens (PhosphoSolutions, Aurora, CO). Anti-pS892 in
GABABR2 (UCL-72) was used as described previously (Couve et al.,
2002). Antibodies were raised against GST-fusion proteins encoding
the C-tails of GABABR1 and R2 in both guinea pigs and chickens.
Sera were affinity purified on immobilized antigens before use as out-
lined previously (Calver et al., 2001; Couve et al., 2001).
Cell Culture and Transfection
Hippocampal cultures were prepared as described previously (Couve
et al., 2002, 2004b). Ten- to twelve-day-in-vitro hippocampal neurons
were transfected using Effectene (Qiagen, Valencia, CA; Jacob et al.,
2005). HEK-293 cells expressing Kir 3.1 and 3.2 channels (GIRK cells;
Leaney et al., 2000) were transfected by calcium phosphate using
1:5:1 ratios of GABABR1, R2, and GFP constructs, respectively (Couve
et al., 2002).
Neuronal Transfection and Anoxia
Dissociated E18 hippocampal neurons were transfected with 3 mg of
CMV based expression constructs encoding N-terminally FLAG-
tagged R2F (Couve et al., 2002) or R2FS783A using 3 mg of DNA per
5 3 106 neurons using the Rat Nucleofector kit (Amaxa). Cells
were used after 10–15 DIV (Couve et al., 2004b; Kittler et al., 2004;
Jacob et al., 2005). For anoxia, neurons were exposed to media
containing 10 mM Na+ azide and 1 mM glucose for 5 min at 37C.
Neurons were then re-fed with conditioned media and cultured for
a further 24 hr. To measure neuronal survival after this time period,
live neurons were stained with trypan blue, then washed extensively
before chilling on ice prior to immunohistochemistry with FLAG anti-
body. Neurons were then fixed and the number of FLAG-positive
surviving neurons (trypan blue negative) was calculated for each
expression construct.
Expression Constructs
Expression constructs encoding the rat GABABR1 and R2 subunits
modified with N-terminal extracellular FLAG epitopes, GFP, GST-R1.
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have all been described previously (Couve et al., 2001; Woods et al.,
2000).
GST Affinity Purification Assays
GST-fusion proteins encoding the C-tails of GABABR1 subunits were
expressed and purified as outlined previously (Couve et al., 2001,
2004b). For affinity purification GST-fusion proteins were immobilized
on agarose and exposed to crude brain membranes solubilized in
a buffer containing 1% Triton X-100, 150 mM NaCl, 50 mM Tris
(pH7.6), 5mMEGTA, 5mMEDTA, 50mMNaF, 1mMNaorthovanadate,
100 mM PMSF, and 10 mg/ml leupeptin, pepstatin, antipain, and apro-
tinin. After extensive washing in a buffer supplemented with 0.5M
NaCl, bound material was subjected to immunoblotting. Bound mate-
rial was also subjected to in vitro kinase assays in a buffer containing
10mM Tris (pH 7.5), 10 mMMgCl2, and 5 mCi
32Pg-ATP with or without
100 mM 50AMP for 10 min at 37C followed by SDS-PAGE (Brandon
et al., 1999a, 1999b).
Immunoprecipitation
Crude brain membranes were solubilized in a buffer containing 2%
CHAPS, 150 mM NaCl, 50 mM Tris (pH 7.6), 5 mM EGTA, 5 mM
EDTA, 50 mM NaF, 10 mM Na pyrophosphate, 1 mM Na orthovana-
date, 10 mM PMSF, and 10 mg/ml leupeptin, pepstatin, antipain, and
aprotinin. Lysates were then subjected to immunoprecipitation with
antibodies immobilized on protein A sepharose (Couve et al., 2002),
and precipitated material was then subjected to SDS-PAGE followed
by immunoblotting with antibodies against GABAB receptors or AMPK.
Immunoblot Analysis and Biotinylation
Cell surface biotinylation of neurons using NHS-Biotin and subsequent
immunoblotting with GABAB antibodies using [
125I]-coupled anti-rabbit
IgG and quantified using a phospho-imager was performed as detailed
previously (Couve et al., 2004b; Fairfax et al., 2004).
Immunofluorescence
Hippocampal neurons were processed for immunohistochemistry un-
der both permeabilized (+ 0.05% Triton X-100) and nonpermeabilized
conditions using the following primary antibodies: Anti-pS892 1:1000;
Anti-pS783 1:500; anti-R1 1:1000; and anti-R2 1:5000 (Couve et al.,
2002). Images were then collected on a Bio-Rad Radiance II micro-
scope. All channels were first background subtracted and the thresh-
old value was determined for each culture and used for all images from
that culture. Quantification of fluorescence levels was performed on
neuronal processes extending from the cell body in the plane of focus.
Pixel intensity was then determined and measured in 2–3 mm2 areas of
interest using MetaMorph software (Universal Imaging).
Immunohistochemistry
Animals were deeply anesthetized and intracardially perfused with sa-
line solution followed by 4% paraformaldehyde. Brains were removed,
post-fixed overnight, and cryoprotected in 30% sucrose. Free-floating
sections were cut at 40 mm using a freezing microtome and stored
at20C in cryoprotective solution (30% sucrose, 30% ethylenglycol,
1% polyvinylpyrrolidone in PBS) until processing. Sections were
washed in PBS and incubated for 10min in 0.1%H2O2 to block endog-
enous peroxidase activity. After washing in PBS sections were incu-
bated for 2 hr in blocking solution (2% normal horse serum, 0.5%
BSA, and 0.3% Triton X-100 in PBS) followed by incubation for 48 hr
at 4C inblocking solution containing theprimary antibody.After rinsing
in PBS sectionswere incubated in blocking solution containing biotiny-
lated anti-rabbit or guinea pig antibody for 2 hr at room temperature,
then rinsed in PBS and incubated for 1 hr in ABC solution (Vectastain
Elite ABC kit, Vectorlabs). After washing, sections were incubated for
10 min in diaminobenzidine (peroxidase substrate) containing nickel
chloride as an enhancing reagent. The reaction was terminated by
washing twice in water. Sections were mounted onto slides, air-dried,Ndehydrated through graded alcohols followed by xylenes, and then
mounted for viewing. Sections were visualized with an Olympus
BX51 microscope (Olympus Optical) and the optical density was ob-
tained usingMetaMorph software (Universal Imaging Corporation).
In Vitro Phosphorylation, Peptide Mapping,
and Phospho-Amino Acid Analysis
GST-fusion proteins were phosphorylated in vitro using 100–1000 U of
AMPK in the presence or absence of 100 mM 50AMP using 5–50 mCi of
32Pg-ATP and a final ATP concentration of 50 mM for 30 min at 30C.
Purified AMPK was purchased from Upstate Biotechnology (Lake
Placid, NY) and had an activity in excess of 4000 U/mg in the presence
of 100 mM 50AMP. Phosphorylation was then assessed by autoradiog-
raphy and quantified using a phospho-imager. Tryptic peptide map-
ping and phospho-amino acid analysis were performed as described
previously (Brandon et al., 1999a).
Off-Line HPLC and On-Line HPLC-Tandem Mass Spectrometry
In parallel with samples used for TLC tryptic mapping, digests of
in vitro GST-CR2 fusion proteins were analyzed using capillary
RP-HPLC. Radiolabeled samples (estimated 5 pmol peptides) were
loaded on a 150 mm 3 10 cm Microsil C8 column (Ultra-Plus II Micro
LC, Micro-Tech Scientific) and 5 min fractions were collected with a
robotic microfraction collector (Probot, Dionex). Fraction samples were
spotted and quantitated using a phospho-imager (Typhoon, Molecular
Dynamics). In parallel, in vitro digests and off-line fractionation was
performed using fusion proteins phosphorylated in the absence of
32P. Digests of these nonradioactive samples (1 ml, estimated 1 pmol
peptides) were analyzed by nanoflow reverse phase liquid chromatog-
raphy (Ultimate LC Packings, Dionex) coupled on-line to a quadrupole-
orthogonal time-of-flight tandemmass spectrometer (MS) (QSTAR XL,
Applied Biosystems/MDS Sciex) using methods described previously
(Huang et al., 2001). The QSTAR MS was first operated in an informa-
tion-dependent mode in which each full MS scan (1 s acquisition) was
followed by MS/MS scan (3 s acquisition for MS/MS scan), where the
most abundant peptide molecular ions were dynamically selected for
low energy CID. Tandem MS/MS spectra were analyzed using both
Mascot and a development version of Protein Prospector (Huang
et al., 2001).
Patch Clamp Electrophysiology
Membrane currents were recorded from single GIRK cells using the
whole-cell patch-clamp configuration in conjunction with an Axopatch
1-C amplifier. Patch pipettes (resistances 3–5 MU) were pulled from
thin-walled borosilicate glass and filled with a solution containing
120mMKCl, 2 mMMgCl2, 11 mMEGTA, 30 mMKOH, 10mMHEPES,
1 mM CaCl2, 1 mM guanine triphosphate, and 2 mM adenosine tri-
phosphate, with the addition of components as listed in the text, which
include 14mM creatine phosphate, 1 mM adenosine monophosphate,
1 mMmetformin, or 1.25 U/ml AMPK (Upstate cell signaling solutions,
NY) (pH 7.0). The cells were continuously perfused with Krebs solution
containing 140 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 2.5 mM CaCl2,
11 mM glucose, and 5 mM HEPES (pH 7.4). Before application of
GABA or baclofen, the K+ concentration of the Krebs solution was in-
creased to 25 mM and the Na+ concentration was reduced to 120mM.
Cells were recorded from 20–48 hr after transfection. Membrane cur-
rents were filtered at 5 kHz (3 dB, 6th pole Bessel, 36 dB/octave)
and stored onto a Dell Pentium III computer for later analysis with
Clampex 8. Any change of more than 10% in the resting membrane in-
put conductance or series resistance resulted in the recording being
discarded. Peak amplitude GABA-activated K+ currents were deter-
mined at 70 mV holding potential. Drugs and solutions were rapidly
applied to the cells using a modified Y-tube positioned approximately
300 mm from the recorded cell. To construct concentration-response
relationships for GABA, the current (I) was measured in the presence
of each concentration of GABA applied at 3 min intervals. The currentseuron 53, 233–247, January 18, 2007 ª2007 Elsevier Inc. 245
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where the EC50 represents the concentration of GABA ([A]) inducing
50% of the maximal K+ current evoked by a saturating concentration
of GABA, and nH is the Hill coefficient. For the analysis of current run-
down, GABA- or baclofen-activated current amplitudes were mea-
sured at 3 min intervals, and the resulting time stability relationships
were fitted with a monoexponential function of the form:
y = yo +A,e
ðt=tÞ
where y is the GABA/baclofen current amplitude at time t, yo is the re-
sidual amplitude at the end of drug application, A represents the am-
plitude, and t is the decay time constant. The fit was determined using
a Marquadt nonlinear least squares routine.
Yeast Two-Hybrid Screens
Yeast two-hybrid screens were performed as described previously
(Restituito et al., 2005). The bait plasmid containing the sequence cor-
responding to the C-tails of GABABR1 (pMW101-CR1) was used to
screen a rat brain cDNA library in yeast vector pJG4-5. Potential inter-
actions were analyzed by growth on plates lacking leucine, uracil,
tryptophan, and histidine and confirmed by galactose-dependency
and b-galactosidase assays. All positive interactions were confirmed
by retransformation into the EGY48 strain and were also confirmed
with empty vector and bait encoding the C-tail of the R2 subunit.
Transient Middle Cerebral Artery Occlusion Surgery
Adult male Wistar rats (290–310 g) were anesthetized with 3% isoflur-
ane in 70% nitrous oxide and 30% oxygen through a nose cone.
Temperature was maintained at 37C throughout the surgery using a
heating lamp. Transient MCAO was induced for 90 min using the intra-
luminal suture method (Longa et al., 1989). Briefly, an 18 mm length of
4-0 monofilament nylon suture coated with poly-L-lysine (Belayev
et al., 1996) and bearing a flame-rounded tip was inserted into the
external carotid artery and advanced through the internal carotid to
occlude the origin of the middle cerebral artery (MCA). Ninety minutes
later the rats were reanesthetized and the suture was withdrawn to
allow for reperfusion of cerebral blood flow. Sham operated controls
were subjected to the same surgery but without advancement of the
suture into theMCA. Two hours following reperfusion, rats were deeply
anesthetized and perfused transcardially with 50 ml of saline followed
by 200 ml of freshly made 4% paraformaldehyde in PBS. Brains were
extracted and post-fixed for 2 hr in 4% paraformaldehyde, then pro-
cessed for immunohistochemistry.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/53/2/233/DC1/.
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